Literature DB >> 21116724

Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI.

Nickolas Zaller1, Alexandra Jeronimo, Jeffrey Bratberg, Patricia Case, Josiah D Rich.   

Abstract

Increased access to sterile syringes among injection drug users (IDUs) has been correlated with reduced syringe sharing. Many states, including Rhode Island, have legalized non-prescription (NP) sale of syringes in pharmacies. Previous studies have suggested that training pharmacists to provide HIV-related services to IDUs may be an important opportunity to engage IDUs and provide them with such services. However, it is not clear to what extent pharmacy staff are willing to expand their roles in providing services to IDUs who come in to purchase syringes. We recruited pharmacists and pharmacy staff from the 48 pharmacies indicating NP sale of syringes in the greater Providence, RI area, to participate in an online survey consisting of demographic information; views about the current syringe laws in Rhode Island; willingness to provide HIV-related services, including referral for HIV testing, substance use treatment, and medical and social services, to IDUs; and past experiences with IDU customers. One hundred and forty-six individuals completed the online survey (32 pharmacies, 114 pharmacy staff). Most participants were employed by chain pharmacies (92%). Most participants thought that pharmacies are important resources for IDU customers (77%) and that they would be willing to provide health and prevention information/referrals to IDU customers who purchase NP syringes (59%). With respect to willingness to offer HIV prevention-related services, access to confidential space and concern about personal safety had the strongest associations with willingness to provide HIV prevention services (OR, 4.3 and 0.1, respectively). As the nature of the retail pharmacy shifts, researchers, pharmacy executives, and health care officials can build upon the willingness of pharmacists and pharmacy staff in order to address the health needs of injection drug users and other underserved populations.

Entities:  

Mesh:

Year:  2010        PMID: 21116724      PMCID: PMC3005095          DOI: 10.1007/s11524-010-9503-z

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  17 in total

1.  The impact of a needle exchange's closure.

Authors:  R S Broadhead; Y van Hulst; D D Heckathorn
Journal:  Public Health Rep       Date:  1999 Sep-Oct       Impact factor: 2.792

2.  Strategies to optimize the impact of needle exchange programs.

Authors:  J D Rich; L L Strong; M Mehrotra; G Macalino
Journal:  AIDS Read       Date:  2000-07

3.  Bridge to services: drug injectors' awareness and utilization of drug user treatment and social service referrals, medical care, and HIV testing provided by needle exchange programs.

Authors:  Judith Porter; David Metzger; Roseanne Scotti
Journal:  Subst Use Misuse       Date:  2002-09       Impact factor: 2.164

4.  Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island.

Authors:  Josiah D Rich; Erika G Martin; Grace E Macalino; Rowan V Paul; Susan McNamara; Lynn E Taylor
Journal:  J Am Pharm Assoc (Wash)       Date:  2002 Nov-Dec

5.  Pharmacists' attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado.

Authors:  Beth A Lewis; Stephen K Koester; Trevor W Bush
Journal:  J Am Pharm Assoc (Wash)       Date:  2002 Nov-Dec

6.  Individual and structural influences shaping pharmacists' decisions to sell syringes to injection drug users in Atlanta, Georgia.

Authors:  Jennifer Taussig; Benjamin Junge; Scott Burris; T Stephen Jones; Claire E Sterk
Journal:  J Am Pharm Assoc (Wash)       Date:  2002 Nov-Dec

7.  More pharmacists in high-risk neighborhoods of New York City support selling syringes to injection drug users.

Authors:  Phillip O Coffin; Jennifer Ahern; Stacy Dorris; Lori Stevenson; Crystal Fuller; David Vlahov
Journal:  J Am Pharm Assoc (Wash)       Date:  2002 Nov-Dec

Review 8.  Syringe exchange programs: Impact on injection drug users and the role of the pharmacist from a U.S. perspective.

Authors:  Alkiviadis G Nacopoulos; Andrea J Lewtas; Maria M Ousterhout
Journal:  J Am Pharm Assoc (2003)       Date:  2010 Mar-Apr 1

9.  New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access.

Authors:  P O Coffin; B P Linas; S H Factor; D Vlahov
Journal:  J Urban Health       Date:  2000-12       Impact factor: 3.671

10.  Health care utilization among young adult injection drug users in Harlem, New York.

Authors:  A Cronquist; V Edwards; S Galea; M Latka; D Vlahov
Journal:  J Subst Abuse       Date:  2001
View more
  14 in total

1.  Missed opportunities for HIV screening in pharmacies and retail clinics.

Authors:  Caitlin Dugdale; Nickolas Zaller; Jeffrey Bratberg; William Berk; Timothy Flanigan
Journal:  J Manag Care Spec Pharm       Date:  2014-04

2.  Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley.

Authors:  Robin A Pollini
Journal:  J Am Pharm Assoc (2003)       Date:  2017-08-12

3.  Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015.

Authors:  Thomas J Stopka; Ashley Donahue; Marguerite Hutcheson; Traci C Green
Journal:  J Am Pharm Assoc (2003)       Date:  2017-02-08

4.  Pharmacists and harm reduction: A review of current practices and attitudes.

Authors:  Tyler Watson; Christine Hughes
Journal:  Can Pharm J (Ott)       Date:  2012-05

5.  Pharmacy staff characteristics associated with support for pharmacy-based HIV testing.

Authors:  Silvia Amesty; Shannon Blaney; Natalie D Crawford; Alexis V Rivera; Crystal Fuller
Journal:  J Am Pharm Assoc (2003)       Date:  2012 Jul-Aug

6.  Reality and feasibility for pharmacy-delivered services for people who inject drugs in Xichang, China: Comparisons between pharmacy staff and people who inject drugs.

Authors:  Yi Yang; Carl Latkin; Rongsheng Luan; Cui Yang
Journal:  Int J Drug Policy       Date:  2015-06-09

7.  The Role of Pharmacies in the HIV Prevention and Care Continuums: A Systematic Review.

Authors:  Natalie D Crawford; Sky Myers; Henry Young; Donald Klepser; Elyse Tung
Journal:  AIDS Behav       Date:  2021-01-02

8.  Pharmacist attitudes and provision of harm reduction services in North Carolina: an exploratory study.

Authors:  Rachel A Parry; William A Zule; Christopher B Hurt; Donna M Evon; Sarah K Rhea; Delesha M Carpenter
Journal:  Harm Reduct J       Date:  2021-07-08

9.  Access to syringes for HIV prevention for injection drug users in St. Petersburg, Russia: syringe purchase test study.

Authors:  Ekaterina V Fedorova; Roman V Skochilov; Robert Heimer; Patricia Case; Leo Beletsky; Lauretta E Grau; Andrey P Kozlov; Alla V Shaboltas
Journal:  BMC Public Health       Date:  2013-03-01       Impact factor: 3.295

10.  Orienting patients to greater opioid safety: models of community pharmacy-based naloxone.

Authors:  Traci C Green; Emily F Dauria; Jeffrey Bratberg; Corey S Davis; Alexander Y Walley
Journal:  Harm Reduct J       Date:  2015-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.